Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
about
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosisCobalamin deficiency, hyperhomocysteinemia, and dementiaMolecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P componentInflammation and Alzheimer's diseaseSortilin Fragments Deposit at Senile Plaques in Human CerebrumAmyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid depositsA quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.Presenilin-1 is associated with Alzheimer's disease amyloidMeningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)Up-regulated production and activation of the complement system in Alzheimer's disease brain.Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.Tissue factor antigen in senile plaques of Alzheimer's disease.Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathyUltrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathyLactotransferrin immunocytochemistry in Alzheimer and normal human brain.Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivoSearch for amyloid-binding proteins by affinity chromatography.Human scleral elastic system: an immunoelectron microscopic study.Efflux transport of serum amyloid P component at the blood-brain barrier.Complexes of amyloid-beta and cystatin C in the human central nervous system.Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid.Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.A kinetic aggregation assay allowing selective and sensitive amyloid-β quantification in cells and tissues.Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease.The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: implications for Alzheimer disease.CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.A primed state exists in vivo following histological regression of amyloidosis.
P2860
Q24562844-7B8EDE44-56C0-414D-AAF7-CA7127724D77Q24609123-4F8C8AF2-6B41-4CCF-883F-186D9DAF937FQ27654862-8D87CB82-161A-4C39-8CD9-03C98F1B8AC7Q28138617-648FA802-149F-4A83-86F2-3C62EAA491C6Q33770251-2BE76047-ED0D-4791-B011-56063BD3BF92Q33893017-D13221A2-F441-475C-9FEC-F03E0C833099Q34671631-8476224B-D3E3-4175-8A2F-5E105F5C93C1Q35023878-39E4F05C-3219-4CBE-93F0-EBD0CB9DB935Q35501399-2A32B37F-E075-4DFA-8D18-DFF6E8E320EBQ35634151-5729869D-4C61-4202-BB9C-60EDA956524CQ35763893-9282245C-32A1-4ABF-957E-0BA09BDB261FQ35774204-AB3DA6A6-4383-4508-89C9-F23AB8A25602Q35786312-F5B407AE-851E-4AC3-940D-D29D18F6C76AQ35811731-8A016548-9426-4563-8180-8D715729F698Q35817146-F9AD19F4-0265-480A-8771-3263FBB71371Q35823366-3A678C8D-0CBE-4A20-961D-F7DA8EC40A30Q35830833-1563C0D8-9AD0-4E6F-A463-F460B0AF9341Q35831830-164AB551-9F7C-44F7-9D33-F0C67494BE75Q35831964-B2C995F1-0950-4380-9CAA-3A2B2B1468E0Q35832768-2A45E227-237F-499F-B836-C53097C9CF99Q35833354-C3BEF82D-FD40-4B08-8E0C-D303E2E60D54Q35833402-5C25BD54-EA61-4D74-A1CD-0091B7C21862Q35921884-3AB150DF-6AB6-49BC-A7A2-538D2EA61423Q36635583-1426F94C-806B-482D-B454-1F9E254C5030Q36880203-82430192-B189-4BC6-BD7C-0B4724E8A059Q37310065-6992894B-4576-4556-89B8-C7EAF46C75D7Q37337462-4DE8F349-1154-4DE7-AC85-F1E2690A8C41Q37474236-7A026DEC-F47D-46C0-8474-FCF377138F88Q41517888-06E6F368-28E6-42D2-BE9F-02012ADA865FQ41542097-21EF3818-04E4-4348-859E-366AD3974DCDQ41853798-9201EED0-3ED0-42FB-9F08-0EA093CFE992Q41886432-B025D2CC-0373-4321-9833-F7B1308E4374Q42026475-74A0A706-CABB-4CD0-9D93-DBB0B77F3CD2Q42161240-F5BE06C7-FDC2-4D4E-8FBC-B237006CB5B8Q42322241-4DFDF70F-A33C-4C30-BA60-1B0211C32D8DQ42396970-27CBE6B3-9918-4A87-A103-19D50081706CQ45003207-3ADD8036-CF8B-4E0A-9F69-A9D3E0A09319
P2860
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Isolation and characterization ...... types of cerebral amyloidosis.
@en
Isolation and characterization ...... types of cerebral amyloidosis.
@nl
type
label
Isolation and characterization ...... types of cerebral amyloidosis.
@en
Isolation and characterization ...... types of cerebral amyloidosis.
@nl
prefLabel
Isolation and characterization ...... types of cerebral amyloidosis.
@en
Isolation and characterization ...... types of cerebral amyloidosis.
@nl
P2093
P1476
Isolation and characterization ...... types of cerebral amyloidosis.
@en
P2093
Frangione B
Larrondo-Lillo M
Shelanski ML
van Duinen S
P304
P577
1988-04-01T00:00:00Z